Compile Data Set for Download or QSAR
Report error Found 110 of affinity data for UniProtKB/TrEMBL: Q9ESG6
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343131(2-(2-cyanopyrimidin-5-yl)-N-(3-ethylphenyl)-4-o-to...)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343129(2-(4-cyanopyridin-3-yl)-N-(3-ethylphenyl)-4-o-toly...)
Affinity DataIC50: 3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343886((R)-4-(4-(2,2,2-trifluoro-1-hydroxyethyl)phenyl)-7...)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343132(2-(3,5-dimethylisoxazol-4-yl)-N-(3-ethylphenyl)-4-...)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620480(CHEMBL5399275)
Affinity DataIC50: 4.80nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620477(CHEMBL5420363)
Affinity DataIC50: 5.60nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620476(CHEMBL5404195)
Affinity DataIC50: 6.80nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343888((R)-4-(4-(2,2-difluoro-1-hydroxyethyl)phenyl)-7-(4...)
Affinity DataIC50: 8nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343120(4-(2,6-dimethylphenyl)-N-(3-ethylphenyl)-2-(pyridi...)
Affinity DataIC50: 9nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343128(2-(benzo[d][1,3]dioxol-5-yl)-N-(3-ethylphenyl)-4-o...)
Affinity DataIC50: 10nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343130(N-(3-ethylphenyl)-2-(pyrimidin-5-yl)-4-o-tolyl-7,8...)
Affinity DataIC50: 12nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620482(CHEMBL5432717)
Affinity DataIC50: 12nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343885(4-(4-(2,2,2-trifluoro-1-hydroxyethyl)phenyl)-7-(4-...)
Affinity DataIC50: 13nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343127(N-(3-ethylphenyl)-2-(quinolin-3-yl)-4-o-tolyl-7,8-...)
Affinity DataIC50: 13nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584883(CHEMBL5074765)
Affinity DataIC50: 13nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343877(7-(4-fluoro-2,6-dimethylbenzyloxy)-4-(thiophen-3-y...)
Affinity DataIC50: 14nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343877(7-(4-fluoro-2,6-dimethylbenzyloxy)-4-(thiophen-3-y...)
Affinity DataIC50: 14nMAssay Description:Inhibition of mouse P2Y14 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343094(2-(4-cyanophenyl)-N-(3-ethylphenyl)-4-o-tolyl-7,8-...)
Affinity DataIC50: 16nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584890(CHEMBL5079102)
Affinity DataIC50: 16nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620473(CHEMBL5438846)
Affinity DataIC50: 16nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584893(CHEMBL5083619)
Affinity DataIC50: 18nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50566405(CHEMBL4864408)
Affinity DataIC50: 19nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14 receptor expressed in HEK293 cells preincubated with compound for 30 mins followed by flu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2022
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343884(4-(4-(methylsulfonyl)phenyl)-7-(4-(trifluoromethyl...)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50543257(CHEMBL4645216)
Affinity DataIC50: 21nMAssay Description:Inhibition of MRS4174 binding to mouse P2Y14R expressed in HEK293 cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50456168(CHEMBL1800685)
Affinity DataIC50: 22nMAssay Description:Displacement of Alexafluor488 labeled 4-(4-(1-(4-(1-(6-(4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-3-carboxybenzamido)hexyl)-1H-1,2,3-triazol-4-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50456168(CHEMBL1800685)
Affinity DataIC50: 22nMAssay Description:Inhibition of MRS4174 binding to mouse P2Y14R expressed in HEK293 cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343095(N-(3-ethylphenyl)-2-(4-fluorophenyl)-4-o-tolyl-7,8...)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343876(7-(2,6-dimethylbenzyloxy)-4-(thiophen-3-yl)-2-naph...)
Affinity DataIC50: 26nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584894(CHEMBL5076127)
Affinity DataIC50: 26nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50620481(CHEMBL5417310)
Affinity DataIC50: 26nMAssay Description:Displacement of fluorescent tracer 4-(4-(1-(4-(1-(6-(3-carboxylato-4-(3-iminio-3H-xanthen-9-yl)benzamido)hexyl)-4,5-dihydro-1H-pyrrol-3-yl)butyl)pipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2024
Entry Details
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343109(N-(3-(1-fluoroethyl)phenyl)-2-(pyridin-3-yl)-4-o-t...)
Affinity DataIC50: 29nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343125(N-(3-ethylphenyl)-2-(3-fluorophenyl)-4-o-tolyl-7,8...)
Affinity DataIC50: 30nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50541998(CHEMBL4642592)
Affinity DataIC50: 30nMAssay Description:Displacement of Alexafluor488 labeled 4-(4-(1-(4-(1-(6-(4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-3-carboxybenzamido)hexyl)-1H-1,2,3-triazol-4-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50541998(CHEMBL4642592)
Affinity DataIC50: 30nMAssay Description:Inhibition of MRS4174 binding to mouse P2Y14R expressed in HEK293 cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584891(CHEMBL5085823)
Affinity DataIC50: 34nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50541997(CHEMBL4649855)
Affinity DataIC50: 38nMAssay Description:Displacement of Alexafluor488 labeled 4-(4-(1-(4-(1-(6-(4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-3-carboxybenzamido)hexyl)-1H-1,2,3-triazol-4-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584895(CHEMBL5076678)
Affinity DataIC50: 41nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584889(CHEMBL5083773)
Affinity DataIC50: 43nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343121(4-(2-chloro-6-methylphenyl)-N-(3-ethylphenyl)-2-(p...)
Affinity DataIC50: 50nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343887((S)-4-(4-(2,2,2-trifluoro-1-hydroxyethyl)phenyl)-7...)
Affinity DataIC50: 51nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343122(4-(2,6-dichlorophenyl)-N-(3-ethylphenyl)-2-(pyridi...)
Affinity DataIC50: 51nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343878(4-(thiophen-3-yl)-7-(4-(trifluoromethoxy)phenyl)-2...)
Affinity DataIC50: 54nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50543255(CHEMBL4640370)
Affinity DataIC50: 56nMAssay Description:Inhibition of MRS4174 binding to mouse P2Y14R expressed in HEK293 cells pre-incubated for 30 mins before MRS4174 addition and further incubated for 3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343090(N-(3-ethylphenyl)-4-o-tolyl-2-p-tolyl-7,8-dihydrop...)
Affinity DataIC50: 62nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343103(N-(3-ethylphenyl)-2-(pyridin-3-yl)-4-o-tolyl-7,8-d...)
Affinity DataIC50: 81nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343089(N-(3-ethylphenyl)-2-phenyl-4-o-tolyl-7,8-dihydropy...)
Affinity DataIC50: 87nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584896(CHEMBL5087295)
Affinity DataIC50: 91nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584904(CHEMBL5093465)
Affinity DataIC50: 102nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50584886(CHEMBL5090079)
Affinity DataIC50: 103nMAssay Description:Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetP2Y purinoceptor 14(Mouse)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343872(7-(2,6-dimethylbenzyloxy)-4-phenyl-2-naphthoic aci...)
Affinity DataIC50: 110nMAssay Description:Antagonist activity at mouse P2Y14 receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed
Displayed 1 to 50 (of 110 total ) | Next | Last >>
Jump to: